The anti-inflammatory and immunological properties of SGLT-2 inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s40618-023-02162-9.pdf
Reference82 articles.
1. Bendotti G, Montefusco L, Lunati ME et al (2022) The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharmacol Res. https://doi.org/10.1016/j.phrs.2022.106320
2. Zelniker TA, Braunwald E (2020) Mechanisms of cardiorenal effects of sodium–glucose cotransporter 2 inhibitors. JACC 75:13. https://doi.org/10.1016/j.jacc.2019.11.031
3. Lunati ME, Cimino V, Gandolfi A, Fiorina P (2022) SGLT2-inhibitors are effective and safe in the elderly: The SOLD study. Pharmacol Res. https://doi.org/10.1016/j.phrs.2022.106396
4. Lazzaroni E (2022) Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study. Pharmacol Res. https://doi.org/10.1016/j.phrs.2022.106374
5. Schlosser J, Umpierrez G, Weinstock R et al (2022) Standards of Medical Care in Diabetes. Diabetes Care 45:S125–S143. https://doi.org/10.2337/dc22-S009
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?;Journal of Veterinary Pharmacology and Therapeutics;2024-07-13
2. Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review;International Journal of Preventive Medicine;2024-06
3. Obesity-related asthma: new insights leading to a different approach;Current Opinion in Pulmonary Medicine;2024-03-04
4. Response to: Correspondence on ‘SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy’ by Zhaoet al;Annals of the Rheumatic Diseases;2024-01-03
5. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications;Therapeutic Advances in Endocrinology and Metabolism;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3